Muscimol as a treatment for nerve injury-related neuropathic pain: a systematic review and meta-analysis of preclinical studies
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Muscimol’s quick onset and GABAergic properties make it a promising candidate for the treatment of pain. This systematic review and meta-analysis of preclinical studies aimed at summarizing the evidence regarding the efficacy of muscimol administration in the amelioration of nerve injury-related neuropathic pain. Methods: Two independent researchers performed the screening process in Medline, Embase, Scopus and Web of Science extracting data were extracted into a checklist designed according to the PRISMA guideline. A standardized mean difference (SMD [95% confidence interval]) was calculated for each. To assess the heterogeneity between studies, I2 and chi-square tests were utilized. In the case of heterogeneity, meta-regression and subgroup analyses were performed to identify the potential source. Results: Twenty-two articles met the inclusion criteria. Pooled data analysis showed that the administration of muscimol during the peak effect causes a significant reduction in mechanical allodynia (SMD = 1.78 [1.45–2.11]; P < 0.0001; I2 = 72.70%), mechanical hyperalgesia (SMD = 1.62 [1.28–1.96]; P < 0.0001; I2 = 40.66%), and thermal hyperalgesia (SMD = 2.59 [1.79–3.39]; P < 0.0001; I2 = 80.33%). This significant amendment of pain was observed at a declining rate from 15 minutes to at least 180 minutes post-treatment in mechanical allodynia and mechanical hyperalgesia, and up to 30 minutes in thermal hyperalgesia (P < 0 .0001). Conclusions: Muscimol is effective in the amelioration of mechanical allodynia, mechanical hyperalgesia, and thermal hyperalgesia, exerting its analgesic effects 15 minutes after administration for up to at least 3 hours.
Abstract
Background: Muscimol’s quick onset and GABAergic properties make it a promising candidate for the treatment of pain. This systematic review and meta-analysis of preclinical studies aimed at summarizing the evidence regarding the efficacy of muscimol administration in the amelioration of nerve injury-related neuropathic pain. Methods: Two independent researchers performed the screening process in Medline, Embase, Scopus and Web of Science extracting data were extracted into a checklist designed according to the PRISMA guideline. A standardized mean difference (SMD [95% confidence interval]) was calculated for each. To assess the heterogeneity between studies, I2 and chi-square tests were utilized. In the case of heterogeneity, meta-regression and subgroup analyses were performed to identify the potential source. Results: Twenty-two articles met the inclusion criteria. Pooled data analysis showed that the administration of muscimol during the peak effect causes a significant reduction in mechanical allodynia (SMD = 1.78 [1.45–2.11]; P < 0.0001; I2 = 72.70%), mechanical hyperalgesia (SMD = 1.62 [1.28–1.96]; P < 0.0001; I2 = 40.66%), and thermal hyperalgesia (SMD = 2.59 [1.79–3.39]; P < 0.0001; I2 = 80.33%). This significant amendment of pain was observed at a declining rate from 15 minutes to at least 180 minutes post-treatment in mechanical allodynia and mechanical hyperalgesia, and up to 30 minutes in thermal hyperalgesia (P < 0 .0001). Conclusions: Muscimol is effective in the amelioration of mechanical allodynia, mechanical hyperalgesia, and thermal hyperalgesia, exerting its analgesic effects 15 minutes after administration for up to at least 3 hours.
참고문헌 (58)
- "Physiology, pain, StatPearls" (2023)[URL]
- Lee S, "Central neuropathic pain in spinal cord injury", Crit Rev Phys Rehabil Med, 25, pp.159~172 (2013)
- Norouzkhani N, "Effect of virtual reality-based interventions on pain during wound care in burn patients; a systematic review and meta-analysis", Arch Acad Emerg Med, 10, pp.e84~ (2022)
- Farahmand Rad R, "Efficacy of sumatriptan", placebo versus sumatriptan, Arch Acad Emerg Med, pp.2022, 10[DOI]
- Hunt C, "Prevalence of chronic pain after spinal cord injury : a systematic review and metaanalysis", Reg Anesth Pain Med, 46, pp.328~336 (2021)
- Jensen TS, "A new definition of neuropathic pain", Pain, 152, pp.2204~2205 (2011)
- Scholz J, "The IASP classification of chronic pain for ICD-11:chronic neuropathic pain", Pain, 160, pp.53~59 (2019)
- Miclescu A, "Chronic neuropathic pain after traumatic peripheral nerve injuries in the upper extremity : prevalence, demographic and surgical determinants, impact on health and on pain medication", Scand J Pain, 20, pp.95~108 (2019)
- Burke D, "Neuropathic pain prevalence following spinal cord injury : a systematic review and meta-analysis", Eur J Pain, 21, pp.29~44 (2017)
- Finnerup NB, "Pain and dysesthesia in patients with spinal cord injury : a postal survey", Spinal Cord, 39, pp.256~262 (2001)
- Deng Y, "Clinical practice guidelines for the management of neuropathic pain : a systematic review", BMC Anesthesiol, 16, pp.12~ (2016)
- Bates D, "A comprehensive algorithm for management of neuropathic pain", Pain Med, 20(Suppl 1), pp.S2~S12 (2019)
- Bernetti A, "Neuropathic pain and rehabilitation : a systematic review of international guidelines", Diagnostics (Basel), 11, pp.74~ (2021)
- Cavalli E, "The neuropathic pain : an overview of the current treatment and future therapeutic approaches", Int J Immunopathol Pharmacol, 33 (2019)
- Azizkhani R, "Topical lidocaine plus diclofenac as a local anesthetic agent in central venous catheterization;a randomized controlled clinical trial", Arch Acad Emerg Med, 9, pp.e63~ (2021)
- Hinton T, "Reference Module in Biomedical Sciences" (2018), Elsevier
- Duncan BR, "Volatile anesthetics and O2 activate TASK-1", 3 by weak H-bonding with X-gate uncharged Arg-245: the major molecular mechanism for carotid body hypoxic sensitivity and further insights into fighter pilot +Gz-induced LOC
- Johnston GA, "Muscimol as an ionotropic GABA receptor agonist", Neurochem Res, 39, pp.1942~1947 (2014)
- Li YH, "The protective effect of muscimol against systemic inflammatory response in endotoxemic mice is independent of GABAergic and cholinergic receptors", Can J Physiol Pharmacol, 100, pp.665~678 (2022)
- Hollister LE, "New class of hallucinogens : GABA-enhancing agents", Drug Dev Res, 21, pp.253~256 (1990)
- Wei D, "The use of GRADE approach in systematic reviews of animal studies", J Evid Based Med, 9, pp.98~104 (2016)
- Hama A, "Combinations of intrathecal gamma-amino-butyrate receptor agonists and Nmethyl-d-aspartate receptor antagonists in rats with neuropathic spinal cord injury pain", Eur J Pharmacol, 683, pp.101~108 (2012)
- Hosseini M, "The effect of intrathecal administration of muscimol on modulation of neuropathic pain symptoms resulting from spinal cord injury; an experimental study", Emerg (Tehran), 2, pp.151~157 (2014)
- Hosseini M, "Simultaneous intrathecal injection of muscimol and endomorphin-1 alleviates neuropathic pain in rat model of spinal cord injury", Brain Behav, 10, pp.e01576~ (2020)
- 전영훈, "백서에서 신경압박 손상에 의해 유발된 과민반응에서 척추 및 말초 GABA-A와 B 수용체 작용제에 의한 완화효과", The Korean Journal of Pain, 19(1), pp.4~4 (2006), 대한통증학회
- 이재희, "Are Spinal GABAergic Elements Related to the Manifestation of Neuropathic Pain in Rat?", The Korean Journal of Physiology & Pharmacology, 14(2), pp.59~69 (2010), 대한약리학회
- Lee MC, "Modulation of spinal GABAergic inhibition and mechanical hypersensitivity following chronic compression of dorsal root ganglion in the rat", Neural Plast, 2015, pp.924728~ (2015)
- Moon HC, "Suppressed GABAergic signaling in the zona incerta causes neuropathic pain in a thoracic hemisection spinal cord injury rat model", Neurosci Lett, 632, pp.55~61 (2016)
- Moon HC, "Reduced GABAergic neuronal activity in zona incerta causes neuropathic pain in a rat sciatic nerve chronic constriction injury model", J Pain Res, 10, pp.1125~1134 (2017)
- Pedersen LH, "Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury", Pain, 127, pp.17~26 (2007)
- Jiang H, "Sensitization of neurons in the central nucleus of the amygdala via the decreased GABAergic inhibition contributes to the development of neuropathic pain-related anxiety-like behaviors in rats", Mol Brain, 7, pp.72~ (2014)
- Rashid MH, "Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism", Brain Res, 953, pp.53~62 (2002)
- Rode F, "Centrally-mediated antinociceptive actions of GABA(A)receptor agonists in the rat spared nerve injury model of neuropathic pain", Eur J Pharmacol, 516, pp.131~138 (2005)
- Sadeghi M, "Evaluation of the GABAA receptor expression and the effects of muscimol on the activity of wide dynamic range neurons following chronic constriction injury of sciatic nerve in rats", Basic Clin Neurosci, 12, pp.651~666 (2021)
- Seno MDJ, "The critical role of amygdala subnuclei in nociceptive and depressive-like behaviors in peripheral neuropathy", Sci Rep, 8, pp.13608~ (2018)
- Wei H, "Descending modulation of neuropathic hypersensitivity by dopamine D2 receptors in or adjacent to the hypothalamic A11cell group", Pharmacol Res, 59, pp.355~363 (2009)
- Yowtak J, "Effect of antioxidant treatment on spinal GABA neurons in a neuropathic pain model in the mouse", Pain, 154, pp.2469~2476 (2013)
- Zarrindast MR, "GABA mechanisms and antinociception in mice with ligated sciatic nerve", Pharmacol Toxicol, 89, pp.79~84 (2001)
- Dias QM, "The lesion of dorsolateral funiculus changes the antiallodynic effect of the intrathecal muscimol and baclofen in distinct phases of neuropathic pain induced by spinal nerve ligation in rats", Brain Res Bull, 124, pp.103~115 (2016)
- Gwak YS, "Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury", J Neurotrauma, 23, pp.1111~1124 (2006)
- Hwang JH, "The effect of spinal GABA receptor agonists on tactile allodynia in a surgicallyinduced neuropathic pain model in the rat", Pain, 70, pp.15~22 (1997)
- LaGraize SC, "GABAA but not GABAB receptors in the rostral anterior cingulate cortex selectively modulate pain-induced escape", avoidance behavior, 2007, pp.204, 182~194
- Nasirinezhad F, "Comparative efficacy of GABAA and GABAB receptor agonists in pain alleviation in a spinal cord injury model of neuropathic pain", Neurophysiology, 51, pp.322~331 (2019)
- Xu Q, "A brief comparison of the pathophysiology of inflammatory versus neuropathic pain", Curr Opin Anaesthesiol, 24, pp.400~407 (2011)
- Kocot-Kępska M, "Peripheral mechanisms of neuropathic pain-the role of neuronal and non-neuronal interactions and their implications for topical treatment of neuropathic pain", Pharmaceuticals (Basel), 14, pp.77~ (2021)
- Campbell JN, "Mechanisms of neuropathic pain", Neuron, 52, pp.77~92 (2006)
- Enna SJ, "The role of GABA in the mediation and perception of pain", Adv Pharmacol, 54, pp.1~27 (2006)
- Kondeva-Burdina M, "Effects of Amanita muscaria extract on different in vitro neurotoxicity models at sub-cellular and cellular levels", Food Chem Toxicol, 132, pp.110687~ (2019)
- Miletic G, "Muscimol prevents long-lasting potentiation of dorsal horn field potentials in rats with chronic constriction injury exhibiting decreased levels of the GABA transporter GAT-1", Pain, 105, pp.347~353 (2003)
- Terayama R, "Reorganization of synaptic inputs to spinal dorsal horn neurons in neuropathic pain", Int J Neurosci, 132, pp.1210~1216 (2022)
- Disorbo A, "Time-dependent retrograde amnesic effects of muscimol on conditioned taste aversion extinction", Pharmacol Biochem Behav, 92, pp.319~326 (2009)
- Puschner B, "Veterinary toxicology", pp.915~925 (2007), Academic Press
- Waldvogel HJ, "GABA and sleep: molecular, functional and clinical aspects", pp.73~93 (2010), Springer Basel
- Ochoa-de la Paz LD, "The role of GABA neurotransmitter in the human central nervous system, physiology, and pathophysiology", Rev Mex Neuroci, 22, pp.67~76 (2021)
- Moss MJ, "Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002-2016", Clin Toxicol (Phila), 57, pp.99~103 (2019)
- Ahmadzadeh K, "Lack of concordance between reporting guidelines and risk of bias assessments of preclinical studies : a call for integrated recommendations", Int J Surg, 109, pp.2557~2558 (2023)
- Shiao R, "Neuropathic pain after spinal cord injury : challenges and research perspectives", Neurotherapeutics, 15, pp.635~653 (2018)
- Gray P, "Acute neuropathic pain : diagnosis and treatment", Curr Opin Anaesthesiol, 21, pp.590~595 (2008)